Financial News
Latest News about DRNA
Recent news which mentions DRNA
10 Biggest Price Target Changes For Thursday
December 09, 2021
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 9, 2021
December 09, 2021
From Benzinga
4 Reasons Arrowhead Pharmaceuticals Could Be the Next Biotech Buyout
November 23, 2021
From Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For November 19, 2021
November 19, 2021
From Benzinga
54 Biggest Movers From Yesterday
November 19, 2021
From Benzinga
Mid-Afternoon Market Update: Dow Falls 75 Points; Dicerna Pharmaceuticals Shares Spike Higher
November 18, 2021
From Benzinga
From Benzinga
Rivian Plunges, but This Under-the-Radar Nasdaq Stock Is Soaring
November 18, 2021
From Motley Fool
12 Health Care Stocks Moving In Thursday's Intraday Session
November 18, 2021
From Benzinga
Mid-Day Market Update: Macy's Surges After Q3 Results; Amtech Systems Shares Plunge
November 18, 2021
From Benzinga
44 Stocks Moving In Thursday's Mid-Day Session
November 18, 2021
From Benzinga
Why Dicerna Pharmaceuticals Stock Is Rocketing Higher Today
November 18, 2021
From Motley Fool
From InvestorPlace
LCID, RIVN, FSR: Why Are EV Stocks Down Today?
November 18, 2021
From InvestorPlace
DRNA Stock: The $3B Novo Nordisk Deal That Has Dicerna Pharma Shares Skyrocketing Today
November 18, 2021
From InvestorPlace
From Benzinga
Novo Nordisk Swallows Dicerna In $3.3B Buyout: All You Need To Know
November 18, 2021
From Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
November 18, 2021
From Benzinga
The Daily Biotech Pulse: J&J To Spin-off Consumer Health Business, AstraZeneca Earnings, Embattled Emergent To Buy Back Shares
November 12, 2021
From Benzinga
Dicerna Pharmaceuticals's Return On Capital Employed Overview
November 10, 2021
Tickers
DRNA
From Benzinga
Dicerna Pharmaceuticals, Inc (DRNA) Q3 2021 Earnings Call Transcript
November 09, 2021
Tickers
DRNA
From Motley Fool
The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data
November 09, 2021
From Benzinga
The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More
November 08, 2021
From Benzinga
The Daily Biotech Pulse: Merck's Oral COVID-19 Pill Authorized In UK, Novartis Cashes Out Of Roche, Chimerix Plunges On Data, Evotec IPO
November 04, 2021
From Benzinga
The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline
October 31, 2021
From Benzinga
Dicerna Posts Mixed Nedosiran Data In Rare Kidney Disease Trial
October 19, 2021
Tickers
DRNA
From Benzinga
From Benzinga
Here's Why Inhibrx Stock Is on the Move Today
October 12, 2021
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
